Nonsense Mutation

Nonsense Mutation designates a genetic alteration in which a nucleotide substitution converts a codon encoding an amino acid into a premature stop codon, resulting in truncated protein production that is often non-functional or rapidly degraded. This type of mutation can severely disrupt protein structure and function, leading to loss-of-function phenotypes and contributing to numerous inherited disorders. Nonsense mutations may also trigger nonsense-mediated mRNA decay, reducing transcript levels.

The biopharmaceutical industry develops therapies targeting nonsense mutations through approaches restoring functional protein expression. Readthrough therapies employ small molecules promoting ribosomal bypass of premature stop codons, enabling synthesis of full-length proteins, with applications explored in Duchenne muscular dystrophy and cystic fibrosis. Gene therapy provides alternative strategies by delivering functional gene copies, while mRNA therapy bypasses defective genomic sequences through transient expression of correct protein-coding transcripts. Genome editing approaches such as CRISPR-based correction aim to repair nonsense mutations directly at the DNA level. Challenges include variability in readthrough efficiency, potential off-target effects, and ensuring restored protein function is sufficient for clinical benefit. As genetic medicine expands, nonsense mutations remain important targets for precision therapies.